Skip to content

Gerd Mikus

  • Prof. Dr. med.
  • Deputy head of department
  • Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg
  • 41h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 5322CitationsNumber of citations received by Gerd's publications. Updated daily.

Research interests

opioids drug interactions pharmacogenetics

Co-authors (431)

Publications (5)

  • A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer

    • Schmitz-Winnenthal F
    • Hohmann N
    • Schmidt T
    • et al.
    N/AReaders
    0Citations
    Get full text
  • European Pain Federation position paper on appropriate opioid use in chronic pain management

    • O'Brien T
    • Christrup L
    • Drewes A
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Role of CYP3A4 in kinase inhibitor metabolism and assessment of CYP3A4 activity

    • Mikus G
    • Foerster K
    N/AReaders
    1Citations
    Get full text
  • Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)

    • Schmitt T
    • Mayer-Steinacker R
    • Mayer F
    • et al.
    N/AReaders
    3Citations
    Get full text
  • Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial

    • Schmitz-Winnenthal F
    • Hohmann N
    • Niethammer A
    • et al.
    N/AReaders
    8Citations
    Get full text

Professional experience

Deputy head of department

Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg